Department of Medicine, Centre for Inflammatory Diseases, Monash University, Monash Medical Centre, Clayton, Australia.
Am J Pathol. 2011 Sep;179(3):1188-98. doi: 10.1016/j.ajpath.2011.05.039. Epub 2011 Jul 8.
T helper (Th)17 cells might contribute to immune-mediated renal injury. Thus, we sought to define the time course of IL-17A-induced kidney damage and examined the relation between Th17 and Th1 cells in a model of crescentic anti-glomerular basement membrane glomerulonephritis. Renal injury and immune responses were assessed in wild-type and in IL-17A-deficient mice on days 6, 14, and 21 of disease development. On day 6, when mild glomerulonephritis developed, IL-17A-deficient mice were protected from renal injury. On day 14, when more severe disease developed, protection from renal injury due to IL-17A deficiency was less evident. On day 21, when crescentic glomerulonephritis was fully established, disease was enhanced in IL-17A(-/-) mice, with increased glomerular T-cell accumulation and fibrin deposition, and augmented Th1 responses. Mice lacking the Th17-promoting cytokine, IL-23 (p19), also developed more severe disease than wild-type animals on day 21. In contrast, mice deficient in the key Th1-promoting cytokine, IL-12 (p35), had decreased Th1 and increased Th17 responses and developed less severe crescentic glomerulonephritis than wild-type animals. These studies show that IL-17A contributes to early glomerular injury, but it attenuates established crescentic glomerulonephritis by suppressing Th1 responses. They provide further evidence that Th1 cells mediate crescentic injury in this model and that Th1 and Th17 cells counterregulate each other during disease development.
辅助性 T 细胞 17(Th17)细胞可能参与免疫介导的肾损伤。因此,我们试图确定白细胞介素 17A(IL-17A)诱导的肾脏损伤的时间进程,并在新月体性抗肾小球基底膜肾小球肾炎模型中检查 Th17 细胞与 Th1 细胞之间的关系。在疾病发展的第 6、14 和 21 天,评估野生型和 IL-17A 缺陷型小鼠的肾脏损伤和免疫反应。在第 6 天,当轻度肾小球肾炎发展时,IL-17A 缺陷型小鼠免受肾脏损伤。在第 14 天,当疾病发展更严重时,IL-17A 缺陷型小鼠免受肾脏损伤的保护作用不太明显。在第 21 天,当新月体性肾小球肾炎完全建立时,IL-17A(-/-)小鼠的疾病加重,肾小球 T 细胞积聚和纤维蛋白沉积增加,Th1 反应增强。缺乏 Th17 促进细胞因子白细胞介素 23(p19)的小鼠在第 21 天也比野生型动物发展出更严重的疾病。相比之下,缺乏关键 Th1 促进细胞因子白细胞介素 12(p35)的小鼠表现出降低的 Th1 和增加的 Th17 反应,并且比野生型动物发展出较轻的新月体性肾小球肾炎。这些研究表明,IL-17A 有助于早期肾小球损伤,但通过抑制 Th1 反应减轻已建立的新月体性肾小球肾炎。它们进一步证明 Th1 细胞在该模型中介导新月体性损伤,并且 Th1 和 Th17 细胞在疾病发展过程中相互拮抗。